Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": individual case review analysi

Abrunhosa-Branquinho AN, Bar-Deroma R, Collette S, Clementel E, Liu Y, Hurkmans CW, Feuvret L, Van Beek K, van den Bent M, Baumert BG & Weber DC
Choose the citation style.
Abrunhosa-Branquinho, A. N., Bar-Deroma, R., Collette, S., Clementel, E., Liu, Y., Hurkmans, C. W., … Weber, D. C. (2018). Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": individual case review analysis. Radiotherapy and Oncology, 127(2), 292-298. https://doi.org/10.1016/j.radonc.2018.03.013